MDNews - Mid Penn

Innovations 2017

Issue link: http://viewer.e-digitaledition.com/i/884976

Contents of this Issue

Navigation

Page 9 of 19

BR AIN TUMORS ARE AMONG THE MOST DIFFICULT CONDITIONS TO TRE AT. THE ADOPTION OF MRIŸGUIDED L A SER ABL ATION GIVES PENN STATE NEUROSCIENCE INSTITUTE SURGEONS AN INNOVATIVE TOOL IN THEIR TUMORŸFIGHTING ARMAMENTARIUM. DEPENDENT UP ON THE pat holog y of each patient, treatment following a bra in t umor dia g nosis va ries. Of ten, patients with malignant lesions require a combination of treatments, such as surgery followed by chemotherapy or radiation therapy. However, if ca ncer recurs or patients are not candidates for first-line surgical tumor excision, these strategies may be limited. For these patients, MRI- g uided laser ablation could present an excellent alternative. LEADING-EDGE TECHNOLOGY "The concept of heating parts of the brain to selectively damage certain areas isn't new, but the means to do this in a safe, e‡ective way have been lacking," says Brad Zacharia, MD, director of brain tumor and skull base surgery at Penn State Neuroscience Institute. "Several sequential innovations in modern laser ablation techniques have made this a viable treatment option." These innovations include the development of a specia lized laser applicator — the Penn State Neuroscience Institute team uses Medtronic's Visualase laser ablation system — and MRI thermography. With computer-g uided assista nce, surgeons thread a thin catheter containing the laser applicator through the brain to the lesion. After the applicator is in place, patients enter an MRI machine. To monitor heat delivery in real-time, physicians use MRI thermography while the laser heats and destroys the targeted tissue. This ensures accurate, safe treatment of the lesion while minimizing damage to other areas of the brain. The procedure is less inva sive tha n traditional surgical techniques, so recovery time is shorter. Most patients are discharged the day after surgery, and physicians do not have to delay chemotherapy or radiation therapy while waiting for patients' incisions to heal. EXPLORING TREATMENT INDICATIONS MRI-guided laser ablation may be most advantageous for patients with comorbid conditions or tumors situated in di¢cult- to-access areas of the brain that preclude them from surgery, as well as those with disease recurrence. Because the treatment uses light energ y instead of radiation, physicians may also o‡er it to patients who have had prior radiation therapy. Additionally, MRI-guided laser ablation is e‡ective in managing radiation necrosis, an inflammator y reaction to radiation therapy. Delayed radiation necrosis a‡ects as many as 50 percent of patients who have received stereotactic radiosurgery, according to an article published in the American Journal of Neuroradiology, and can cause significant neurologic symptoms. Penn State Health Milton S. Hershey Medica l Center is the only hospita l in the a rea that offers MR I-g uided laser ablation for patients with brain tumors and radiation necrosis — a population for whom travel can be challenging. Local access to laser ablation allows referring providers to help patients in central Pennsylvania a nd the surrounding a reas stay closer to home; treatment a rra ngements a re much more accommodating than having to schedule travel time and coordinate out-of-town treatment. To learn more about MRI-guided laser ablation or to refer a patient for care at Penn State Neuroscience Institute, call 717-531-3828. ■ " As an academic medical center, we take seriously our responsibility to provide the latest in care. We offer everything patients can find at major academic medical centers, including Gamma Knife radiosurgery, MRI- guided laser ablation, awake functional mapping and clinical trials — all close to home." BRAD ZACHARIA, MD, DIRECTOR OF BRAIN TUMOR AND SKULL BASE SURGERY AT PENN STATE NEUROSCIENCE INSTITUTE Axial view MRI of Visualase ablation Sagittal view of ablation MRI-guided Laser Ablation EXPANDS OPTIONS FOR BRAIN TUMOR TREATMENT BY TIFFANY PARNELL 1 0A D V A N C E S I N T R E A T M E N T

Articles in this issue

Archives of this issue

view archives of MDNews - Mid Penn - Innovations 2017